About us
Who we are
Governance
Staff
Vacancies
What we do
Members
EuropaBio Members
About Membership
How we work
Healthcare Biotechnology Council
Medicines For Rare Diseases And Children
Patient Bio-Forum
Industrial Biotechnology Council
Food, Feed & Nutrition
Circular Bioeconomy
National Associations Council
SME Platform
Biomanufacturing Platform
Activities
25 Years of Innovation
EFIB
European Biotech Week
News & Events
News
Events
Library
Become a member
✕
05/11/2021
It’s Coming…
12/08/2021
2006: Revolution in HIV treatment. First EMA approval for single tablet regimen taken once a day
02/07/2021
2019: Large scale microbial production of next generation, zero-calorie, non-artificial EVERSWEET™ Stevia sweetener
02/07/2021
1996: Understanding how the immune system recognises virus-infected cells. Nobel Prize for Physiology or Medicine
25/06/2021
Improved food safety through asparaginase produced via genetically modified micro-organisms: reduced acrylamide in cooked food
23/06/2021
It’s Coming…
18/06/2021
2017: First Radioligand therapy (RLT) approved in Europe for the treatment of gastroenteropancreatic neuroendocrine tumours – Lutathera®
18/06/2021
2014: First Industrial Fermentation-derived perfume ingredient Clearwood®
18/06/2021
2007: Landmark European publication behind ‘Knowledge Based Bioeconomy’ in Europe
18/06/2021
2007: First production of spider silk through biotechnology
18/06/2021
2003: Human Genome Project completion
18/06/2021
1996: First European Commission-approved product following European Agency for the Evaluation of Medicinal Products (EMEA, later EMA) recommendation
18/06/2021
2014: Checkpoint inhibitor innovation as key part of cancer immunotherapy
18/06/2021
2016: First curative gene therapy for ADA-SCID approved for infants
16/06/2021
1996: Introduction of law in Italy for early access to drugs (648/1996) to support rare disease patients
16/06/2021
2006: Globally accessible Gene Sequencing Technology
16/06/2021
1997: First clinical trial with D2E7 (Humira), the first fully human monoclonal antibody approved by the US Food and Drug Administration (FDA)
16/06/2021
1999: Messenger RNA (mRNA) patented in relation to therapeutic applications
16/06/2021
2000: Vitamin B2 shifts from chemical synthesis to exclusive biotechnological production in less than 15 years
16/06/2021
2001: First enzyme replacement therapy for to treat Fabry disease approved in the European Union, plus world’s largest database of Fabry disease patients
1
2
Next page
Become a member